X0306 4 2019-12-31 0001325618 IRADIMED CORP IRMD 0001254747 JOHNSON BRENT C/O IRADIMED CORPORATION 1025 WILLA SPRINGS DR. WINTER SPRINGS FL 32708 true Exec. VP. Sales and Mktg Common Stock 2019-12-31 4 M 0 617 A 3183 D Common Stock 2019-12-31 4 F 0 243 23.38 D 2940 D Common Stock 2019-12-31 4 A 0 6000 0.93 A 8940 D Common Stock 2019-12-31 4 S 0 6000 23.79 D 2940 D Restricted Stock Units 2019-12-31 4 M 0 617 0 D Common Stock 617 0 D Stock Option(Right to Buy) 0.93 2019-12-31 4 M 0 6000 0 D 2022-11-01 Common Stock 6000 126468 D Restricted stock units convert into common stock on a one-for-one basis. On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. This transaction was executed in multiple trades at prices ranging from $23.65 to $23.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. /s/ Brent Johnson 2020-01-03